Medical isotopes and radiopharmaceuticals provider MDS Nordion secures an increased supply of cobalt-60, used mainly in sterilization procedures at hospitals, from Russia’s Rosenergoatom. An expansion upon a deal signed in 2005, the new contract calls for the nuclear power utility to increase Ottawa-based MDS Nordion’s shipments of the radioactive isotope by 30% over the next 17 years. “As demand for cobalt-60 increases each year, this contract is great news for the global medical community,” says MDS Nordion president Steve West. “It demonstrates MDS Nordion’s ongoing commitment to provide customers a long-term supply to meet their growing sterilization needs.”